Management is buying the same thing twice: proven demand from one place is being replicated into identified new places r
The model's full reasoning — Q2 2022 call → NOWe need answer YES or NO. Need analyze transcript. Need determine if management describes currently in middle of copying part of business already working into additional places where same demand visible. Need identify specific proven instance, copies being stood up now, demand already identified at destination. Let's parse. Transcript: GoodRx business. They discuss prescription transactions, subscriptions, pharma manufacturer solutions. They mention "we are also prioritizing new product enhancements" and "focused on developing new services and incentives for users to register with GoodRx" to increase touch points. This will add friction. They mention "My Medicine Cabinet" launched last week. But is that copying a proven instance into additional places? No. They mention "vitaCare" acquisition, pharmacy services platform. "gives us valuable capabilities to facilitate the brand location prescription process from start to finish, adds yet another innovative product and enhances our pharma focus capabilities." Not copying existing proven instance into multiple places? It's an acquisition, not standing up copies. They mention "GoodRx providers" with over 825,000 prescribers using since June 2021, more than 300,000 HCPs opted into provider mode. "we believe there is an enormous opportunity for us to meet providers' unique needs with innovative solutions" - not copying. They mention "Pharma Manufacturer Solutions" revenue more than doubling, "continued to increase penetration" - growth within existing offering, not replicating into new locations. They mention "strategic initiative with Mayne Pharma" - a campaign, not copying. Question asks: "does management describe the company as CURRENTLY IN THE MIDDLE OF COPYING A PART OF ITS OWN BUSINESS THAT IS ALREADY WORKING INTO ADDITIONAL PLACES WHERE THE SAME DEMAND IS ALREADY VISIBLE" - Need find if they describe a proven instance and standing up copies. The transcript has no mention of opening new facilities, stores, etc. It's a digital platform. They talk about "we are also prioritizing new product enhancements" and "developing new services and incentives for users to register" - that's product development, not copying proven unit. They mention "we will also be doubling down in our engagement efforts" - not. Maybe "vitaCare" acquisition? They acquired a pharmacy services platform.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| VSEC | VSE Corporation | Q3 2022 | 2022-10-28 | B+ |
| FSLR | First Solar, Inc. | Q3 2022 | 2022-10-28 | C+ |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| GDS | GDS Holdings Limited | Q2 2021 | 2021-08-17 | C+ |
| TPIC | TPI Composites, Inc. | Q3 2018 | 2018-11-11 | C |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| FOLD | Amicus Therapeutics, Inc. | Q1 2018 | 2018-05-08 | C+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| VSAT | Viasat, Inc. | Q4 2017 | 2017-05-23 | C+ |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
GDS · Q2 2021 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a clear, present-tense replication of their proven China-based data center platform into new markets (Hong Kong, Macau, Southeast Asia) where demand is already visible and committed. William Huang explicitly references the “proven” China edge-of-town model (land-and-expand MOUs, 500 000 sqm secured pipeline, hyperscale orders already landed) and states they are “currently developing two purpose-built data centers” in Hong Kong (HK1/HK2) with most capacity “already allocated to strategic customers pending contracts,” plus a new building (HK4) under agreement and a heads-of-agreement for HK3, creating “nearly 80 megawatts of purpose-built capacity through to 2027.” For Macau they have a JV to acquire brownfield sites for redevelopment (20 MW).
FOLD · Q1 2018 → YESThe question is about whether management describes the company as currently copying a proven part of its business into additional places where demand is already visible. YES The transcript shows management describing Galafold as a proven commercial offering (Q1 revenue $16.7M, 300% YoY growth, hundreds of patients, high compliance, 7 approvals, 18 countries with pricing/reimbursement) that is now being replicated into additional markets.
TPIC · Q3 2018 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a proven manufacturing operation (existing dedicated lines and plants in the U.S.